Experiment 927714
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | FALKSON,G: CNAAN,A: SIMSON,IW: DAYAL,Y: FALKSON,H: SMITH,TJ: HALLER,DG:. (1990). A RANDOMIZED PHASE II STUDY OF ACIVICIN AND 4'-DEOXYDOXORUBICIN IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN AN EASTERN COOPERATIVE ONCOLOGY GROUP STUDY.. 13(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | 26 PATIENTS WITH HEPATOCELLULAR CARCINOMA WERE USED IN THIS STUDY. AMONG THE PATIENTS 16 PROGRESSED, 7 WERE UNEVALUABLE FOR RESPONSE AND 3 HAD STABLE DISEASE. THERE WAS 1 LIFE-THREATENING NEUROLOGIC TOXICITY. OTHER TOXICITIES INCLUDED VOMITING AND HEMATOLOGICAL TOXICITIES 20 MG/SQ.M. OF ACIVICIN WAS ADMINISTERED DAILY OVER 72 HOURS AND REPEATED EVERY 3 WEEKS. IN THE SECOND COURSE THE DOSE WAS ESCALATED TO 75 MG/SQ.M. IF NO TOXICITY WAS OBSERVED DURING THE INITIAL INFUSION. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |